The goal of the project is to design, optimise and validate molecular tools to manipulate the excitability of neurons and brain circuits. The project will advance fundamental neuroscience and the treatment of neurological and psychiatric disorders. It will feed into a programme of research into gene therapy for refractory epilepsy, with a view to clinical translation.